Solid Biosciences Inc.
SLDB
$9.54
-$0.39-3.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -207.10M | -191.78M | -174.33M | -167.14M | -154.08M |
| Total Depreciation and Amortization | 1.63M | 1.62M | 1.64M | 1.66M | 1.69M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 26.34M | 24.80M | 23.22M | 24.54M | 25.56M |
| Change in Net Operating Assets | -7.71M | -6.31M | -6.82M | 8.56M | 4.22M |
| Cash from Operations | -186.84M | -171.67M | -156.29M | -132.38M | -122.62M |
| Capital Expenditure | -965.00K | -1.19M | -1.15M | -792.00K | -722.00K |
| Sale of Property, Plant, and Equipment | 85.00K | 85.00K | 85.00K | 5.00K | 5.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -86.21M | 14.87M | -57.39M | -66.11M | -31.90M |
| Cash from Investing | -87.09M | 13.77M | -58.45M | -66.90M | -32.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -446.00K | -588.00K | -723.00K | -648.00K | -525.00K |
| Issuance of Common Stock | 307.91M | 258.88M | 196.85M | 198.57M | 200.53M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -13.64M | -14.55M | -1.68M | -1.68M | -1.68M |
| Cash from Financing | 293.82M | 243.75M | 194.45M | 196.24M | 198.32M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.88M | 85.84M | -20.30M | -3.04M | 43.09M |